Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-05-19 | Alison L. Hannah, age 54. Dr. Hannah will be new to the board of directors. ... The Board has determined that each of Dr. Hannah ... is independent. ... No committees listed for Dr. Hannah. ... The following table provides information concerning the compensation of our non-employee directors for the year ended December 31, 2014. ... No compensation listed for Dr. Hannah. |
| 2016-04-29 | Alison L. Hannah, age 55. Dr. Hannah has served as a director since June 2015. ... Director Compensation ... Alison L. Hannah ... Total ($) 59,217 |
| 2017-04-25 | Alison L. Hannah, age 56. Dr. Hannah has served as a director since June 2015. ... Alison L. Hannah Board Member. ... The following table sets forth the current members of each standing Committee: ... Alison L. Hannah Audit Committee, Nominating and Corporate Governance Committee. ... Director Compensation ... Alison L. Hannah 50,000 Fees earned in cash, 61,307 Stock Awards, 26,390 Warrant/Option Awards, Total 137,697. |
| 2018-04-20 | Alison L. Hannah, age 57. Dr. Hannah has served as a director since June 2015. ... Dr. Hannah has significant healthcare knowledge having spent the last 15 years as a consultant in the field of oncology drug development with over 20 years of experience working with biopharmaceutical companies. |
| 2019-04-22 | Alison L. Hannah, age 58. Dr. Hannah has served as a director since June 2015. She serves on the Audit Committee and the Nominating and Corporate Governance Committee. Director compensation table shows Alison L. Hannah total compensation as $176,289. |
| 2020-04-15 | Alison L. Hannah, age 59. Dr. Hannah has served as a director since June 2015. Dr. Hannah has over 29 years’ experience in the development of investigational cancer chemotherapies. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19